(INM)
0.00
0.00 (0.00%)
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
0.00
0.00 (0.00%)
InMed Pharmaceuticals Inc., klinik bosqichdagi farmatsevtika kompaniyasi, Qo'shma Shtatlarda retsept bo'yicha mahsulotlar portfelini ishlab chiqadi. Kompaniya InMed Pharmaceuticals va BayMedica Commercial nomli ikkita segment orqali faoliyat yuritadi. InMed Pharmaceuticals segmenti kannabinoidlarga asoslangan farmatsevtika mahsulotlarini tadqiq etadi va ishlab chiqadi. BayMedica Commercial segmenti sog'liq va salomatlik sanoati uchun noyob kannabinoidlarni ishlab chiqarish va sotish uchun o'ziga xos ishlab chiqarish texnologiyalarini ishlab chiqadi. Uning retsept bo'yicha mahsulotlariga noyob kannabinoidlar va tibbiy ehtiyojlari qondirilmagan kasalliklarni davolash uchun yangi kannabinoid analoglari kiradi. Kompaniyaning asosiy mahsuloti INM-755 ni o'z ichiga oladi, bu kannabinol asosidagi topikal teri kremi bo'lib, u epidermoliz bulloza kasalligini davolash uchun 2-bosqichli klinik sinovlarni yakunlagan. Shuningdek, u selektiv er-xotin CB1/CB2 agonist vazifasini bajaruvchi kichik molekulali birikma INM-089 va neyrodegenerativ kasalliklar uchun INM-900, shuningdek, Altsgeymer kasalligini davolash uchun kichik molekula INM-901 ni ishlab chiqadi. Bundan tashqari, kompaniya farmatsevtik darajadagi kannabinoidlar uchun integratsiyalashgan biosintezga asoslangan ishlab chiqarish yondashuvi IntegraSyn ni; va kannabixromen, kannabisitran, kannabidivarin va tetrahidrokannabivarinni taklif etadi. Kompaniya ilgari Cannabis Technologies Inc. nomi bilan tanilgan va 2014 yil oktyabr oyida InMed Pharmaceuticals Inc. nomini o'zgartirgan. InMed Pharmaceuticals Inc. 1981 yilda ro'yxatga olingan va Vankuver, Kanadada joylashgan.
| Ism | Lavozim |
|---|---|
| Colin Clancy | Senior Director of Investor Relations |
| Dr. Eric Chih-Hsien Hsu Ph.D. | Senior Vice President of Preclinical Research & Development |
| Dr. Sazzad Hossain M.Sc., Ph.D. | Co-Founder |
| Dr. Shane A. Johnson Ph.D. | Senior VP & GM of BayMedica |
| Mr. Eric A. Adams B.S. Chem., M.I.B. | President, CEO & Director |
| Mr. Jerry P. Griffin | Vice President of Sales & Marketing |
| Mr. Michael Woudenberg P.Eng. | Chief Operating Officer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-03-20 | S-3 | ea0282026-s3_inmed.htm |
| 2026-03-09 | 8-K | form8k.htm |
| 2026-03-06 | 8-K | ea0279869-8k_inmed.htm |
| 2025-12-18 | 8-K | form8k.htm |
| 2025-12-15 | 8-K | ea0269687-8k_inmed.htm |
| 2025-12-08 | S-8 | ea0268706-s8_inmed.htm |
| 2025-11-19 | 8-K | ea0266453-8k_inmed.htm |
| 2025-11-06 | 10-Q | ea0262541-10q_inmed.htm |
| 2025-11-03 | DEFA14A | ea0263038-defa14a_inmed.htm |
| 2025-10-24 | 10-K/A | ea0262392-10ka1_inmed.htm |
| Ms. N. Netta Jagpal |
| CFO & Corporate Secretary |